Best Agrolife (539660) investor relations material

Executive summary

• Q1 FY27 saw resilient performance with revenue up 4% year-on-year to ₹396 crore and profit after tax doubling to ₹41 crore, driven by margin expansion, operational efficiencies, and a shift to patented products.

• Patented products now contribute 64-65% of branded sales, up from 45% last year, with strong farmer acceptance and repeat purchases; new launches like Fluzam and Cubax Power Extra gained traction.

• Focus on innovation, operational efficiency, and expanding market presence to drive sustainable value.

• Working capital improved with inventory reduced by 6% year-on-year.

Financial highlights

• Revenue from operations grew 4% year-on-year to ₹396 crore; gross profit increased 32% year-on-year to ₹146 crore.

• Gross margin expanded to 37% from 29% year-on-year, and EBITDA margin improved to 20% from 12%, reflecting a favorable product mix and higher patented product volumes.

• EBITDA rose 70% year-on-year to ₹78 crore; PAT more than doubled to ₹41 crore, with PAT margin improving to 10% from 5%.

• Operating expenses rose only 4-4.5% year-on-year despite continued investment in market development.

• Sequential turnaround from Q4 FY26, with all key metrics returning to profitability.

Outlook and guidance

• Management expects Q2 to be strong as delayed demand shifts from Q1, contingent on continued rainfall and improving monsoon conditions.

• Patented products are expected to remain 60-70% of branded sales, supporting higher margins.

• Revenue CAGR targeted at 10-15% over the next 3-4 years, with sustainable EBITDA margins of 13-14%.

• No new product launches planned for the remainder of the year; pipeline launches depend on regulatory approvals.

• Focus will remain on innovation, expanding market presence, and operational efficiency to drive sustainable growth.